Industrious Ventures has announced its investment in Antares, a company developing innovative nuclear microreactors aimed at providing reliable energy solutions for critical missions in defense and space operations.
Target Information
Antares is a pioneering company focused on developing compact nuclear microreactors, designed specifically for critical applications in various challenging environments. With a particular emphasis on the 100 kWe to 1 MWe range, their innovative technology is geared towards delivering reliable power solutions in locations beyond traditional power grid reach, such as military bases, remote operations, and space missions. Their microreactors employ a sodium heat-pipe-cooling system, allowing for a simplistic design with enhanced durability and reduced maintenance needs, making them ideally suited for operations facing logistical difficulties.
Founded by Jordan Bramble (CEO) and Julia DeWahl (President), Antares has gathered a highly skilled team with extensive knowledge in nuclear engineering and regulatory practices, thus positioning the company favorably to navigate the complexities of the energy sector. Currently, Antares has secured over $12 million in federal contracts with key stakeholders, showcasing the company's capacity for executing initiatives that support national security and space exploration.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The United States energy landscape is undergoing a significant transformation as policymakers actively support advanced nuclear technologies, particularly following the passing of the ADVANCE Act. This legislation, which received broad bipartisa
Similar Deals
Avery Dennison Corporation → Addionics
2025
FTAI Infrastructure → Long Ridge Energy & Power
2025
Tamarack Global → Moxion Power
2023
Energize Ventures → Patch
2023
Industrious
invested in
Antares
in 2025
in a Series B deal